On Tuesday 10 December, Esmée Bakker and Yonne Peters were awarded a Christine Mohrmann stipend. The purpose of the grant is to encourage researchers to continue their academic career after completing their PhDs. The grant – 5000 euros each – gives them an opportunity to spend time at another university, preferably one abroad.
Esmée Bakker, theme Vascular damage, examines the effects of physical (in)activity on cardiovascular health within the area of primary and secondary prevention. Her goal is to determine how much physical activity is needed to improve health and to determine the health risks of a sedentary lifestyle. Esmée will use the Mohrmann stipend to perform innovative research at the Norwegian University of Science and Technology (Trondheim, Norway). She will use data of the HUNT-study, which is a large population-based study collecting detailed data about physical fitness, (in)activity patterns and cardiovascular health.
The incidence of esophageal adenocarcinoma has risen by 6-fold over the last few decades in the Netherlands. Less than 4 out of 5 patients with esophageal cancer are still alive after 5 years. Yonne Peters, theme Tumors of the digestive tract, is working on a new strategy for early detection of (pre-stages) of esophageal cancer using breath analysis with an electronic nose. She examines the reliability and acceptance of this screening test. The ultimate goal is to implement this breath test as a screening test in general practice or population screening to detect esophageal cancer at an early stage and increase survival. Yonne will use the Mohrmann stipend for a visit to the MRC Cancer Unit in Cambridge, experts in the field of esophageal cancer screening.
Read more on the Radboud University website 'Mohrmann Stipend for ten female PhD candidates'
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more